Information  X 
Enter a valid email address

Cloudcall Group PLC (CALL)

  Print      Mail a friend

Wednesday 14 August, 2019

Cloudcall Group PLC

Appointment of Nominated Adviser and Sole Broker

RNS Number : 9463I
Cloudcall Group PLC
14 August 2019
 

14 August 2019 

CloudCall Group plc 

("Cloudcall", the "Company" or the "Group")

Appointment of Nominated Adviser and Sole Broker

The Company is pleased to announce the appointment of Canaccord Genuity Limited to act as its Nominated Adviser and Sole Broker with immediate effect.

 

For further information, please contact:

CloudCall Group plc

Simon Cleaver, Chief Executive Officer

Paul Williams, Chief Financial Officer

                                                        

Tel:  +44 (0)20 3587 7188

Canaccord Genuity Limited

Simon Bridges

Richard Andrews

Tel: +44 (0)20 7523 8000

 

                                 

About CloudCall Group Plc

CloudCall is a software and unified communications business that has developed and provides a suite of cloud-based software and communications products and services. CloudCall's products and services are aimed at enabling organisations to leverage their customer data to enable more effective communications.

The CloudCall suite of software products allows companies to fully integrate telephony and messaging capability into their existing CRM software, enabling communications to be made, recorded, logged and categorised from within the customer relationship management (CRM) system with detailed activity reporting and powerful business intelligence capable of being easily generated.

At the end of June 2019, the Company had approximately 150 staff based predominantly in Leicester and London (UK), Boston (US) and Minsk (BY), with just under 37,000 end-users relying on CloudCall technology to power their daily communications.

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
APPDMGMRLFLGLZM

a d v e r t i s e m e n t